Literature DB >> 6209514

Intravenous gammaglobulin for post-encephalitic epilepsy.

P Sandstedt, V Kostulas, L E Larsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6209514     DOI： 10.1016/s0140-6736(84)91585-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  High dose intravenous gamma-globulin in intractable epilepsy of childhood.

Authors:  A Etzioni; M Jaffe; S Pollack; N Zelnik; A Benderly; Y Tal
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

Review 2.  Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.

Authors:  S A Schwartz
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

Review 3.  Clinical significance of IgG subclass deficiency.

Authors:  G Morgan; R J Levinsky
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

4.  Use of intravenous immunoglobulins in drug-resistant epilepsy.

Authors:  A Fois; M Vascotto
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

5.  [Immunoglobulins in the treatment of bacterial meningitis in childhood].

Authors:  R Noack; C Szugs; H Scholz
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

Review 6.  The use of IVIG in neurological disease.

Authors:  A I Levinson
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

7.  Intravenous immunoglobulins for epilepsy.

Authors:  JinSong Geng; JianCheng Dong; Youping Li; HengJian Ni; Kui Jiang; Li Li Shi; GuoHua Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.